719 related articles for article (PubMed ID: 27607058)
1. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
2. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
3. Optimal resection margin for head and neck cutaneous melanoma.
Han AY; Dhanjani S; Pettijohn K; Patel PB; John MAS
Laryngoscope; 2019 Jun; 129(6):1386-1394. PubMed ID: 30408184
[TBL] [Abstract][Full Text] [Related]
4. Survival Differences Between Pediatric Head and Neck Versus Body Melanoma in the Surveillance, Epidemiology, and End Results Program.
Shi K; Camilon PR; Roberts JM; Meier JD
Laryngoscope; 2021 Feb; 131(2):E635-E641. PubMed ID: 32364637
[TBL] [Abstract][Full Text] [Related]
5. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
[TBL] [Abstract][Full Text] [Related]
6. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
7. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma.
Tcheung WJ; Marcello JE; Puri PK; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2011 Aug; 65(2):e37-e42. PubMed ID: 21075477
[TBL] [Abstract][Full Text] [Related]
9. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
10. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
11. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
[TBL] [Abstract][Full Text] [Related]
12. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
14. Cheek Cutaneous Melanomas: A Review of 98 Cases.
Tas F; Erturk K
Ann Plast Surg; 2019 Apr; 82(4):407-410. PubMed ID: 30628930
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
16. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
17. Scalp melanoma and in-transit metastases: a retrospective case-controlled study.
Teng E; Sue GR; Sawh-Martinez R; Nishikawa S; Ariyan S; Natarajan A; Narayan D
Am Surg; 2014 Dec; 80(12):1272-4. PubMed ID: 25513930
[No Abstract] [Full Text] [Related]
18. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
19. Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.
Andersson AP; Gottlieb J; Drzewiecki KT; Hou-Jensen K; Sondergaard K
Cancer; 1992 Mar; 69(5):1153-6. PubMed ID: 1739914
[TBL] [Abstract][Full Text] [Related]
20. Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.
Gastman BR; Zager JS; Messina JL; Cook RW; Covington KR; Middlebrook B; Gerami P; Wayne JD; Leachman S; Vetto JT
Head Neck; 2019 Apr; 41(4):871-879. PubMed ID: 30694001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
